Cancer’s rogue DNA: how ecDNA reshapes itself to survive treatment
A new review in Cellular Oncology argues that treatment resistance in cancer often stems from selection and remodeling of pre-existing ...
A new review in Cellular Oncology argues that treatment resistance in cancer often stems from selection and remodeling of pre-existing ...
A rat study found that the antioxidant compound TBHQ reduced cisplatin-induced cognitive deficits, oxidative stress and hippocampal inflammation.
A new review examines how chemotherapeutic agents damage sperm DNA and germ cells, and what fertility preservation options exist for ...
A single gold nanorod platform combining HER2-targeting, NIR imaging, photothermal heating, and doxorubicin delivery eliminated SK-BR-3 breast tumors in mice ...
A prospective Dutch cohort study found oral cetirizine prevented paclitaxel hypersensitivity reactions as effectively as intravenous clemastine, with 10 percent ...
A new review maps how natural active compounds can self-assemble into carrier-free nanostructures for cancer therapy, while flagging major translational ...
A systematic review and meta-analysis of seven studies in 383 patients found that adding hydroxychloroquine to standard chemotherapy did not ...
A platinum(IV) prodrug covalently attached to mesoporous silica nanoparticles showed significantly greater cytotoxicity than cisplatin in patient-derived oral squamous cell ...
A single-center case series describes curative chemotherapy for lymphoma in five adults with Fontan circulation, highlighting the cardiotoxicity risks of ...
A meta-analysis of six randomized trials found silymarin significantly lowered AST and ALT in chemotherapy patients, with no significant effect ...
A retrospective study of 117 oncology patients found ejection fraction and global longitudinal strain gave discordant results in 41 percent ...
A review in Discover Oncology describes how the gut microbiota can modulate chemotherapy efficacy and resistance through drug sequestration, metabolic ...
A published case report describes a woman whose EBV-positive NK/T-cell lymphoma relapsed inside her eye and later involved her optic ...
A German-Indonesian expert working group argues that baseline and end-of-treatment hearing assessments should be mandated for every child receiving cisplatin ...
A prospective smartphone-based study tracked 13 symptoms three times daily across two chemotherapy cycles in 110 colorectal cancer patients, finding ...
A cost-effectiveness model based on the HARMONi-6 trial finds that ivonescimab plus chemotherapy is unlikely to be cost-effective for advanced ...
A qualitative study of 14 Brazilian patients found that before starting treatment for lung or head and neck cancer, most ...
A systematic review and meta-analysis of six studies covering 2,479 patients found that antibody-drug conjugates significantly improved progression-free and overall ...
Genome sequencing of normal oesophageal tissue shows that chemotherapy and chemoradiotherapy select for distinct mutant clones in healthy cells, including ...
A Bayesian reanalysis of the RELEVANCE trial found extremely low probabilities that rituximab plus lenalidomide was inferior to rituximab plus ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.